+44 (0)20 3910 4640 hello@symmetron.net
  • Twitter
  • Twitter
Symmetron
  • Services
  • Success stories
  • Therapeutic areas
  • Insights
  • The team
  • Careers
  • Contact
Select Page

Market access for immuno-oncology (I-O) therapies in the UK

by Anna Pagotto | Jul 6, 2021 | Market access, NICE, Oncology

Insights Market access for immuno-oncology (I-O) therapies in the UK The rapid development of immuno-oncology (I-O) therapies has transformed the cancer treatment landscape, but health technology assessment (HTA) agencies can decide against covering or reimbursing...
  • March 2023
  • January 2023
  • December 2022
  • August 2022
  • May 2022
  • November 2021
  • October 2021
  • August 2021
  • July 2021
  • Budget impact
  • Clinical trial
  • Cost-effectiveness analysis
  • cost-effectiveness analysis
  • Decision analytic
  • Discrete event simulation
  • Evidence generation
  • Evidence synthesis
  • glossary
  • Health economic modelling
  • Health outcomes
  • Health technology assessment
  • Healthcare
  • Internship
  • Market access
  • Medical affairs
  • NICE
  • Oncology
  • Services
  • Success stories
  • Therapeutic areas
  • Insights
  • The team
  • Careers
  • Contact
  • Privacy Policy
  • LinkedIn
  • Twitter
© 2021 Symmetron Limited